Related references
Note: Only part of the references are listed.PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
B. Shen et al.
BRITISH JOURNAL OF CANCER (2012)
PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells
E. Pestereva et al.
BRITISH JOURNAL OF CANCER (2012)
Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis
Feng Zhang et al.
CELLULAR SIGNALLING (2012)
PPAR gamma, bioactive lipids, and cancer progression
Gregory T. Robbins et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
CD133+liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
Kwan Ho Tang et al.
HEPATOLOGY (2012)
PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma
Elizabeth Charytonowicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma
Wen Yang et al.
JOURNAL OF HEPATOLOGY (2012)
Defining the mode of tumour growth by clonal analysis
Gregory Driessens et al.
NATURE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells
Angelo Cerbone et al.
PLOS ONE (2012)
Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
Arnout G. Schepers et al.
SCIENCE (2012)
A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4
Kyung-Won Min et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Terence Kin Wah Lee et al.
CELL STEM CELL (2011)
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice
Eleni Maniati et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+Cell Populations
Zhaojuan Yang et al.
PLOS ONE (2011)
miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
Stephanie Ma et al.
CELL STEM CELL (2010)
Epigenetic Regulation of Cancer Stem Cell Marker CD133 by Transforming Growth Factor-β
Hanning You et al.
HEPATOLOGY (2010)
Inhibitory Role of Peroxisome Proliferator-Activated Receptor Gamma in Hepatocarcinogenesis in Mice and In Vitro
Jun Yu et al.
HEPATOLOGY (2010)
Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma
Keisuke Kohga et al.
JOURNAL OF HEPATOLOGY (2010)
Peroxisome Proliferator-Activated Receptor-y Inhibits Transformed Growth of Non-Small Cell Lung Cancer Cells through Selective Suppression of Snail
Rashmi Choudhary et al.
NEOPLASIA (2010)
Phase 2 Open-label Study of Single-agent Sorafenib in Treating Advanced Hepatocellular Carcinoma in a Hepatitis B-endemic Asian Population
Thomas Yau et al.
CANCER (2009)
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARγ-dependent and PPARγ-independent pathways
Besstina E. Lyles et al.
CELL CYCLE (2009)
15d-PGJ(2) Induces Apoptosis by Reactive Oxygen Species-mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity
Sung-Won Shin et al.
CLINICAL CANCER RESEARCH (2009)
CD133+ Liver Cancer Stem Cells from Methionine Adenosyl Transferase 1A-Deficient Mice Demonstrate Resistance to Transforming Growth Factor (TGF)-β-Induced Apoptosis
Wei Ding et al.
HEPATOLOGY (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation
Edward Owusu-Ansah et al.
NATURE (2009)
Albumin-Binding and Tumor Vasculature Determine the Antitumor Effect of 15-Deoxy-Δ12,14-Prostaglandin-J2 In Vivo
Jai Prakash et al.
NEOPLASIA (2009)
On the abundance of EpCAM on cancer stem cells
Olivier Gires et al.
NATURE REVIEWS CANCER (2009)
RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells
Dajun Chai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways
Xuwen Gao et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
Novel action of paclitaxel against cancer cells: Bystander effect mediated by reactive oxygen species
Jerome Alexandre et al.
CANCER RESEARCH (2007)
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Shengyong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Nox enzymes and the biology of reactive oxygen
JD Lambeth
NATURE REVIEWS IMMUNOLOGY (2004)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic siqnaling: role of P13-K and Akt kinase upon rac1
M Ozaki et al.
CELL DEATH AND DIFFERENTIATION (2003)
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
RTP Poon et al.
ANNALS OF SURGERY (2000)
Share Paper
